Varaico: Literature-Extracted Genetic Variants

Gene:FAS
Variant:p.H282Y
Back to variants list

FAS

NM_000043.6:p.H282Y

Associated Papers

A polymorphism in the FAM13A gene confers protection against tuberculosis in Brazilian workers exposed to silica.

Castro MCS et al.

Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia, 2025

Genotyping of the gene polymorphisms FASL 844C/T and FAS 670A/G in patients with idiopathic infertility in Iraq.

Manshd AA et al.

Revista Da Associacao Medica Brasileira (1992), 2025

Assessment of the relationship between miR-499C/T (rs3746444) polymorphism and lung carcinoma in Iranian population; a case-control study.

Torabi M et al.

African Health Sciences, 2023

Fas cell surface death receptor/Fas ligand genetic variants in gastric cancer patients: A case-control study.

Asgari R et al.

The Indian Journal of Medical Research, 2022

Genetic polymorphisms and their effects on the severity of silicosis in workers exposed to silica in Brazil.

Castro MCS et al.

Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia, 2022

Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: a systematic literature review and meta-analysis.

Hoxhaj I et al.

Bmc Cancer, 2021

FAS and FASL variations in outcomes of tobacco- and alcohol-related head and neck squamous cell carcinoma patients.

Costa EFD et al.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2020

Identification of a FAS/FASL haplotype associated with endometriosis in Iranian patients.

Akhavan Sales Z et al.

Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 2020

Association between the FAS/FASL Variants and Risk of Male Infertility in Asian Populations; A Systematic Review and Meta-Analysis.

Asgari R et al.

Medicina (kaunas, Lithuania), 2019

The role of FAS, FAS-L, BAX, and BCL-2 gene polymorphisms in determining susceptibility to unexplained recurrent pregnancy loss.

Michita RT et al.

Journal of Assisted Reproduction and Genetics, 2019

A meta-analysis of tumor necrosis factor-α and FAS/FASL polymorphisms with risk of pre-eclampsia.

Lin Y et al.

Hypertension in Pregnancy, 2019

Meta-Analysis of the Association Between FAS Ligand and TRAIL Genetic Polymorphisms and Intervertebral Disc Degeneration Susceptibility in Chinese Han population.

Huang X et al.

Spine, 2018

Status of FAS and FAS Ligand Gene Polymorphisms in Patients with Breast Cancer in Northeastern IRAN.

Jalali SA et al.

Reports of Biochemistry & Molecular Biology, 2018

Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.

Asgari R et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2017

Fas and Fas ligand gene polymorphisms in Turkish patients with Familial Mediterranean Fever.

Ozel EG et al.

Gene, 2017

FAS and FASL genetic polymorphisms impact on clinical outcome of malignant pleural mesothelioma.

El-Hamamsy M et al.

Oncotargets and Therapy, 2016

The association between the SNP rs763110 and the risk of gynecological cancer: a meta-analysis.

Zhou L et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2015

Functional polymorphisms in apoptosis pathway genes and survival in patients with gastric cancer.

Gu D et al.

Environmental and Molecular Mutagenesis, 2014

Association between CD95L polymorphism and cervical cancer risk: evidence from a meta-analysis.

Zhu J et al.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2014

Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.

Wang Z et al.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2014

Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.

Thurner EM et al.

Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [et Al], 2014

Genetic association between the HIF-1α P582S polymorphism and cervical cancer risk: a meta analysis.

Zhu J et al.

International Journal of Clinical and Experimental Pathology, 2014

FAS and FAS-L genotype and expression in patients with recurrent pregnancy loss.

Banzato PC et al.

Reproductive Sciences (thousand Oaks, Calif.), 2013

Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.

Hashemi M et al.

Plos One, 2013

Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients.

Mohammadzadeh A et al.

Rheumatology International, 2012

Renal function and genetic polymorphisms in pediatric heart transplant recipients.

Feingold B et al.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation, 2012

An updated pooled analysis of glutathione S-transferase genotype polymorphisms and risk of adult gliomas.

Yao L et al.

Asian Pacific Journal of Cancer Prevention : Apjcp, 2012

International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Truong T et al.

Carcinogenesis, 2010

Polymorphisms of FAS and FAS ligand genes and risk of skin cancer.

Qureshi A et al.

Journal of Dermatological Science, 2010

The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies.

Zhang Z et al.

European Journal of Human Genetics : Ejhg, 2009

FAS -1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls.

Qiu LX et al.

Human Genetics, 2009

Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.

Park JY et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2009

Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer.

Ter-Minassian M et al.

Carcinogenesis, 2008

Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer.

Ivansson EL et al.

International Journal of Cancer, 2007

Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk.

Crew KD et al.

Carcinogenesis, 2007

Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.

Park SH et al.

Lung Cancer (amsterdam, Netherlands), 2006

Association of a microsatellite in FASL to type II diabetes and of the FAS-670G>A genotype to insulin resistance.

Nolsøe RL et al.

Genes and Immunity, 2006

Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia.

Nolsøe RL et al.

Genes and Immunity, 2005

The -844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE.

Chen JY et al.

Genes and Immunity, 2005

Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients.

Tahoori MT et al.

Clinical and Experimental Rheumatology, 0

Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.

Verim L et al.

In Vivo (athens, Greece), 0

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."